Cancer drug trial halted early: ixabepilone fails to show promise in advanced breast cancer
Disease control
Terminated
This study tested the chemotherapy drug ixabepilone in 13 people with advanced or metastatic breast cancer whose disease had stopped responding to two common types of chemotherapy (anthracyclines and taxanes). The goal was to see if the drug could shrink tumors or slow the cancer…
Phase: PHASE2 • Sponsor: Allarity Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:40 UTC